BRPI1013184A2 - método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral - Google Patents

método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral

Info

Publication number
BRPI1013184A2
BRPI1013184A2 BRPI1013184A BRPI1013184A BRPI1013184A2 BR PI1013184 A2 BRPI1013184 A2 BR PI1013184A2 BR PI1013184 A BRPI1013184 A BR PI1013184A BR PI1013184 A BRPI1013184 A BR PI1013184A BR PI1013184 A2 BRPI1013184 A2 BR PI1013184A2
Authority
BR
Brazil
Prior art keywords
identifying
treatment
condition
oral cavity
compound usable
Prior art date
Application number
BRPI1013184A
Other languages
English (en)
Portuguese (pt)
Inventor
Harsh M Trivedi
Tao Xu
Ying Yang
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of BRPI1013184A2 publication Critical patent/BRPI1013184A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1013184A 2009-04-01 2010-04-01 método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral BRPI1013184A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01
PCT/US2010/029674 WO2010115034A2 (en) 2009-04-01 2010-04-01 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

Publications (1)

Publication Number Publication Date
BRPI1013184A2 true BRPI1013184A2 (pt) 2016-04-12

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013184A BRPI1013184A2 (pt) 2009-04-01 2010-04-01 método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral

Country Status (15)

Country Link
US (1) US8753820B2 (https=)
EP (1) EP2414837B1 (https=)
JP (1) JP5643288B2 (https=)
CN (1) CN102549432B (https=)
AR (1) AR076041A1 (https=)
BR (1) BRPI1013184A2 (https=)
CA (1) CA2753718C (https=)
CO (1) CO6430490A2 (https=)
MX (1) MX2011008439A (https=)
MY (1) MY179250A (https=)
RU (1) RU2523383C2 (https=)
SG (1) SG173461A1 (https=)
TW (1) TWI481870B (https=)
WO (1) WO2010115034A2 (https=)
ZA (1) ZA201106056B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI405565B (zh) * 2009-04-01 2013-08-21 Colgate Palmolive Co 口腔用組成物之抗－骨質流失及抗－牙周附連喪失之功效
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
US20190339269A1 (en) * 2017-01-03 2019-11-07 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
EP3631462A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of gingivitis based on salivary il-1beta and hgf
JP7245174B2 (ja) * 2017-05-24 2023-03-23 コーニンクレッカ フィリップス エヌ ヴェ 唾液のｈｇｆ及びｍｍｐ－８に基づく歯周炎の診断
JP7486316B2 (ja) 2017-05-24 2024-05-17 コーニンクレッカ フィリップス エヌ ヴェ 唾液のｉｌ－１ベータ及びｍｍｐ－９に基づく軽度の又は進行した歯周炎の診断
CN111226118A (zh) 2017-10-27 2020-06-02 加利福尼亚大学董事会 用于牙龈炎的唾液细胞外rna生物标记物
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
CA2176237A1 (en) 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
JP2000512285A (ja) 1996-06-12 2000-09-19 ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン 化粧品および／または薬剤製剤
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
US6696261B2 (en) 1999-12-03 2004-02-24 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020009740A1 (en) 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
JP2006517969A (ja) 2003-02-14 2006-08-03 コンビナトアールエックス インコーポレーティッド 免疫炎症性障害の治療のための組み合わせ療法
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
WO2005039504A2 (en) 2003-10-24 2005-05-06 Eisai Co., Ltd. Compounds and methods for treating toll-like receptor 2-related diseases and conditions
JP2007519894A (ja) 2003-12-03 2007-07-19 ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ 標的としてのカドヘリンの使用
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
JP4934812B2 (ja) * 2004-12-21 2012-05-23 国立大学法人 奈良先端科学技術大学院大学 Ｎｆａｔ２発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
ES2431291T3 (es) 2006-01-10 2013-11-25 Colgate-Palmolive Company Métodos para modular receptores de superficie celular para prevenir o reducir la inflamación
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
US8333981B2 (en) 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
JP5643288B2 (ja) 2014-12-17
WO2010115034A3 (en) 2010-12-29
CN102549432B (zh) 2015-03-25
CA2753718C (en) 2015-06-23
JP2012522994A (ja) 2012-09-27
CN102549432A (zh) 2012-07-04
TWI481870B (zh) 2015-04-21
RU2011144032A (ru) 2013-05-10
US8753820B2 (en) 2014-06-17
EP2414837B1 (en) 2015-06-03
AR076041A1 (es) 2011-05-11
EP2414837A2 (en) 2012-02-08
SG173461A1 (en) 2011-09-29
MY179250A (en) 2020-11-02
TW201102653A (en) 2011-01-16
CA2753718A1 (en) 2010-10-07
MX2011008439A (es) 2011-09-06
ZA201106056B (en) 2015-05-27
CO6430490A2 (es) 2012-04-30
US20120028261A1 (en) 2012-02-02
RU2523383C2 (ru) 2014-07-20
AU2010232593A1 (en) 2011-08-25
WO2010115034A2 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
BRPI0919626A2 (pt) implante dental
IL217540A (en) Oral composition for use in oral disinfection or in treating an oral disease
BRPI0810555A2 (pt) Implante dentário
BRPI0917567A2 (pt) tratamento de doença respiratória
EP2362759A4 (en) SUPPORT FOR A DENTAL IMPLANT
BRPI0916049A2 (pt) "dispositivo para tratamento da cavidade dental e método para tratamento da cavidade dental"
BRPI0909908A2 (pt) implante de válvula cardíaca
EP2081520A4 (en) MEDICAL IMPLANTS
EP2296593A4 (en) MEDICAL HEAD COVER
BRPI1013184A2 (pt) método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral
PL2516002T3 (pl) Preparat do leczenia i/lub zapobiegania stanom chorobowym spowodowanym przez mikroorganizmy z zastosowaniem doustnego urządzenia świetlnego
EP2327448A4 (en) defibrillation catheter
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
EP2378983A4 (en) IMPLANTABLE PROSTHESIS
BRPI0915267A2 (pt) Composto, composição farmacêutica livre de pirogênio, e, método de tratamento de uma doença ou uma condição
EP2323587A4 (en) ACTIVE RELEASE IMPLANTS
BRPI0906461A2 (pt) Composição para o cuidado oral, e, método para aplicar uma composição de cuidado oral na cavidade oral
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
BR112012004135A2 (pt) implante dentário, e, kit de implante dentário
BR112013009970A2 (pt) método para determinar uma característica do ritmo circadiano de um paciente.
BRPI0819642A2 (pt) Método para a formação de uma dentadura para um paciente em uma única visita, e, dentadura
SI2358641T1 (sl) Postopek priprave titanatov
EP2249888A4 (en) BONE IMPLANT COMPOSITE
IT1397349B1 (it) Metodo e kit per la produzione di un prodotto dentale
BRPI1015216A2 (pt) método de tratar ou prevenir uma condição médica em um indivíduo.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]